Developing Organoid Workflows
Organoids hold significant promise for reducing or even replacing animal testing in a range of sectors, including human health and life sciences. Derived from adult stem cells or induced pluripotent stem cells (iPScs), these mini organs better mimic human biology, providing more accurate predictions of drug responses, toxicity, and disease mechanisms. Key organoid applications include drug discovery, personalized medicine, toxicology screening, developmental biology, and cell regenerative medicine. Sartorius Corporate Research is commited to develop streamlined and robust organoid flows.
Our Work
Developing comprehensive workflows
While the utility of organoid models is undeniable, significant challenges remain. Scientists continue to encounter obstacles in achieving consistent, automated and streamlined organoid generation and analysis. To fully harness the potential of organoid technology, Sartorius is leveraging external collaborations to develop a comprehensive workflow that includes organoid generation, end-point analysis, and integrated quality control.
Related Products
Through the integration of various Sartorius tools, we can enhance processes, ensure consistency, and streamline operations. This strategic approach not only improves productivity but also empowers scientist to achieve their goals more effectively, ultimately driving innovation and success.
Developing new ideas with innovative partners
Publications & Knowledge
Sartorius has assembled a wide range of scientific publications, references and knowledge-based articles, as well as webinars and other resources.
Related Content
Contact us
